ラクオリア創薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/03/13 | 771 | 829 | 712 | 780 | -76 | -8.9% | 1,092,500 |
2020/03/12 | 865 | 925 | 855 | 856 | -39 | -4.4% | 654,900 |
2020/03/11 | 929 | 951 | 891 | 895 | -47 | -5% | 540,200 |
2020/03/10 | 878 | 952 | 835 | 942 | +38 | +4.2% | 1,026,600 |
2020/03/09 | 995 | 1,002 | 896 | 904 | -161 | -15.1% | 1,175,900 |
2020/03/06 | 1,060 | 1,091 | 1,055 | 1,065 | -30 | -2.7% | 343,800 |
2020/03/05 | 1,101 | 1,104 | 1,073 | 1,095 | +15 | +1.4% | 280,300 |
2020/03/04 | 1,034 | 1,089 | 1,026 | 1,080 | +40 | +3.8% | 329,300 |
2020/03/03 | 1,089 | 1,099 | 1,031 | 1,040 | -10 | -1% | 456,700 |
2020/03/02 | 1,006 | 1,070 | 997 | 1,050 | +45 | +4.5% | 640,900 |
2020/02/28 | 975 | 1,059 | 975 | 1,005 | -57 | -5.4% | 1,034,800 |
2020/02/27 | 1,110 | 1,127 | 1,041 | 1,062 | -64 | -5.7% | 827,600 |
2020/02/26 | 1,183 | 1,204 | 1,120 | 1,126 | -82 | -6.8% | 665,500 |
2020/02/25 | 1,180 | 1,223 | 1,178 | 1,208 | -64 | -5% | 387,600 |
2020/02/21 | 1,248 | 1,290 | 1,248 | 1,272 | +16 | +1.3% | 261,300 |
2020/02/20 | 1,310 | 1,311 | 1,253 | 1,256 | -42 | -3.2% | 380,100 |
2020/02/19 | 1,228 | 1,302 | 1,228 | 1,298 | +70 | +5.7% | 515,100 |
2020/02/18 | 1,228 | 1,274 | 1,212 | 1,228 | -8 | -0.6% | 377,800 |
2020/02/17 | 1,185 | 1,243 | 1,185 | 1,236 | +9 | +0.7% | 371,900 |
2020/02/14 | 1,213 | 1,234 | 1,197 | 1,227 | +4 | +0.3% | 261,400 |
2020/02/13 | 1,248 | 1,258 | 1,206 | 1,223 | +30 | +2.5% | 474,600 |
2020/02/12 | 1,188 | 1,204 | 1,182 | 1,193 | -3 | -0.3% | 176,400 |
2020/02/10 | 1,190 | 1,196 | 1,172 | 1,196 | +13 | +1.1% | 144,200 |
2020/02/07 | 1,196 | 1,203 | 1,173 | 1,183 | -16 | -1.3% | 143,200 |
2020/02/06 | 1,200 | 1,210 | 1,187 | 1,199 | +9 | +0.8% | 175,100 |
2020/02/05 | 1,210 | 1,222 | 1,189 | 1,190 | -14 | -1.2% | 156,500 |
2020/02/04 | 1,162 | 1,216 | 1,162 | 1,204 | +34 | +2.9% | 228,700 |
2020/02/03 | 1,143 | 1,185 | 1,140 | 1,170 | -24 | -2% | 340,600 |
2020/01/31 | 1,155 | 1,201 | 1,155 | 1,194 | +35 | +3% | 246,900 |
2020/01/30 | 1,230 | 1,240 | 1,151 | 1,159 | -70 | -5.7% | 552,100 |
2020/01/29 | 1,245 | 1,257 | 1,217 | 1,229 | -23 | -1.8% | 215,900 |
2020/01/28 | 1,203 | 1,260 | 1,200 | 1,252 | +39 | +3.2% | 241,900 |
2020/01/27 | 1,201 | 1,243 | 1,201 | 1,213 | -35 | -2.8% | 288,800 |
2020/01/24 | 1,283 | 1,288 | 1,243 | 1,248 | -40 | -3.1% | 385,400 |
2020/01/23 | 1,304 | 1,310 | 1,285 | 1,288 | -25 | -1.9% | 210,900 |
2020/01/22 | 1,297 | 1,325 | 1,282 | 1,313 | +18 | +1.4% | 225,800 |
2020/01/21 | 1,332 | 1,332 | 1,289 | 1,295 | -26 | -2% | 250,100 |
2020/01/20 | 1,310 | 1,342 | 1,301 | 1,321 | +23 | +1.8% | 394,400 |
2020/01/17 | 1,291 | 1,303 | 1,274 | 1,298 | +3 | +0.2% | 208,500 |
2020/01/16 | 1,301 | 1,309 | 1,286 | 1,295 | -10 | -0.8% | 191,500 |
2020/01/15 | 1,292 | 1,309 | 1,289 | 1,305 | +2 | +0.2% | 148,000 |
2020/01/14 | 1,304 | 1,309 | 1,282 | 1,303 | -1 | -0.1% | 180,500 |
2020/01/10 | 1,289 | 1,306 | 1,285 | 1,304 | +12 | +0.9% | 183,300 |
2020/01/09 | 1,310 | 1,314 | 1,278 | 1,292 | +30 | +2.4% | 316,400 |
2020/01/08 | 1,317 | 1,336 | 1,230 | 1,262 | -75 | -5.6% | 1,109,200 |
2020/01/07 | 1,337 | 1,375 | 1,331 | 1,337 | +22 | +1.7% | 444,200 |
2020/01/06 | 1,298 | 1,345 | 1,293 | 1,315 | -26 | -1.9% | 526,000 |
2019/12/30 | 1,427 | 1,437 | 1,338 | 1,341 | +94 | +7.5% | 2,199,800 |
2019/12/27 | 1,238 | 1,256 | 1,221 | 1,247 | +14 | +1.1% | 235,000 |
2019/12/26 | 1,203 | 1,241 | 1,203 | 1,233 | +30 | +2.5% | 401,800 |
1151~
1200
件表示中 / 3268件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ラクオリア | 46,200円 | +138.6% | - | 0.00% | 42.35倍 | 1.78倍 |
|
ファイザー旧国内研究所が前身。導出した発売済み消化器薬等収益柱に成長、低分子創薬に強い |
ソレイジア | 5,000円 | +102.6% | - | 0.00% | - | 5.54倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
ペルセウス | 72,300円 | 0.0% | - | 0.00% | - | 6.06倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体(ADC)開発 |
モダリス | 14,100円 | - | - | 0.00% | - | 8.93倍 |
|
遺伝子治療薬の創薬ベンチャー、切断しない独自のゲノム編集技術に強み。研究開発中心は米国 |
仁 丹 | 211,400円 | +2.4% | +10.4% | 2.60% | 12.36倍 | 0.69倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
市場注目の銘柄
チャート関連のコラム